Advertisement

Inflammatory Reactions to Laryngeal Injection of Hyaluronic Acid Derivatives

      Summary

      Objectives/Hypothesis

      To report the rate and describe the characteristics and management of inflammatory reactions following injection laryngoplasty with hyaluronic acid derivatives.

      Study Design

      Single institution, retrospective review.

      Methods

      Adult and pediatric patients who underwent injection laryngoplasty with hyaluronic acid derivatives from 2013 to 2020 were identified. Demographics, indication for injection, type and volume of injected material, and use of general anesthesia were obtained. When a postoperative inflammatory response occurred, information regarding clinical presentation, timing, and subsequent management was collected.

      Results

      A total of 464 patients who underwent 536 laryngeal injections with hyaluronic acid derivatives were included. There were 365 adult patients (median age 62 years) who underwent 431 injections and 99 pediatric patients (median age 2 years) who underwent 105 injections. The most common indications for injection were abnormal vocal fold mobility (70.3%) and aspiration (83.8%) for adult and pediatric patients, respectively. Juvéderm® was used in 449 cases (79.8% adult, 100% pediatric), and Restylane® was used in the remaining adult cases (20.2%). Procedures were mostly performed under general anesthesia (67.7% adult, 100% pediatric) with median injection volumes of 0.6 mL for adult and 0.3 mL for pediatric patients. An inflammatory reaction occurred following 3 of 536 injections (0.6%), all utilizing Juvéderm®. All three patients presented with stridor, dyspnea, and laryngeal edema within two days of injection. Each patient was admitted for observation and successfully treated with intravenous steroids and inhaled racemic epinephrine. One patient with comorbid pneumonia was intubated and required concomitant treatment with broad-spectrum antibiotics.

      Conclusions

      Inflammatory reactions to hyaluronic acid derivatives used in injection laryngoplasty are rare but represent significant patient morbidity and can be managed with anti-inflammatory and airway stabilizing measures. Patients should be counseled appropriately regarding the risks of injection laryngoplasty with hyaluronic acid derivatives.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosen CA.
        Phonosurgical vocal fold injection: procedures and materials.
        Otolaryngol Clin North Am. 2000; 33: 1087-1096https://doi.org/10.1016/S0030-6665(05)70267-X
        • Cohen MS
        • Zhuang L
        • Simons JP
        • et al.
        Injection laryngoplasty for type 1 laryngeal cleft in children.
        Otolaryngol Head Neck Surg. 2011; 144: 789-793https://doi.org/10.1177/0194599810395082
        • Kwon TK
        • Rosen CA
        • Gartner-Schmidt J.
        Preliminary results of a new temporary vocal fold injection material.
        J Voice. 2005; 19: 668-673https://doi.org/10.1016/j.jvoice.2005.01.009
        • Friedman AD
        • Burns JA
        • Heaton JT
        • et al.
        Early versus late injection medialization for unilateral vocal cord paralysis.
        Laryngoscope. 2010; 120: 2042-2046https://doi.org/10.1002/lary.21097
        • Mahboubi H
        • Mohraz A
        • Verma SP.
        Evaluation of heating and shearing on the viscoelastic properties of calcium hydroxyapatite used in injection laryngoplasty.
        Otolaryngol Head Neck Surg. 2016; 154: 498-501https://doi.org/10.1177/0194599815625206
        • Edwards PC
        • Fantasia JE.
        Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers.
        Clin Interv Aging. 2007; 2: 509-519https://doi.org/10.2147/cia.s382
        • Thibeault SL
        • Klemuk SA
        • Chen X
        • et al.
        In vivo engineering of the vocal fold ECM with injectable HA hydrogels - Late effects on tissue repair and biomechanics in a rabbit model.
        J Voice. 2011; 25: 249-253https://doi.org/10.1016/j.jvoice.2009.10.003
        • Butler JE
        • Hammond TH
        • Gray SD.
        Gender-related differences of hyaluronic acid distribution in the human vocal fold.
        Laryngoscope. 2001; 111: 907-911https://doi.org/10.1097/00005537-200105000-00029
        • Abduljabbar MH
        • Basendwh MA.
        Complications of hyaluronic acid fillers and their managements.
        J Dermatology Dermatologic Surg. 2016; 20: 100-106https://doi.org/10.1016/j.jdds.2016.01.001
        • Pinsky MA
        • Thomas JA
        • Murphy DK
        • et al.
        Juvéderm injectable gel: a multicenter, double-blind, randomized study of safety and effectiveness.
        Aesthetic Surg J. 2008; 28: 17-23https://doi.org/10.1016/j.asj.2007.09.005
        • Friedman PM
        • Mafong EA
        • Kauvar ANB
        • et al.
        Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.
        Dermatologic Surg. 2002; 28: 491-494https://doi.org/10.1046/j.1524-4725.2002.01251.x
        • Perazzo PSL
        • Duprat A de C
        • Lancellotti CLP.
        Histological behavior of the vocal fold after hyaluronic acid injection.
        J Voice. 2009; 23: 95-98https://doi.org/10.1016/j.jvoice.2007.05.006
        • Hertegård S
        • Hallén L
        • Laurent C
        • et al.
        Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold function.
        Laryngoscope. 2002; 112: 2211-2219https://doi.org/10.1097/00005537-200212000-00016
        • Hertegård S
        • Hallén L
        • Laurent C
        • et al.
        Cross-linked hyaluronan versus collagen for injection treatment of glottal insufficiency: 2-Year follow-up.
        Acta Otolaryngol. 2004; 124: 1208-1214https://doi.org/10.1080/00016480410017701
        • Dominguez LM
        • Tibbetts KM
        • Simpson CB.
        Inflammatory reaction to hyaluronic acid: a newly described complication in vocal fold augmentation.
        Laryngoscope. 2017; 127: 445-449https://doi.org/10.1002/lary.26156
        • Rudolf R
        • Sibylle B.
        Laryngoplasty with hyaluronic acid in patients with unilateral vocal fold paralysis.
        J Voice. 2012; 26: 785-791https://doi.org/10.1016/j.jvoice.2011.11.007
        • Verma SP
        • Dailey SH.
        Office-based injection laryngoplasty for the management of unilateral vocal fold paralysis.
        J Voice. 2014; 28: 382-386https://doi.org/10.1016/j.jvoice.2013.10.006
        • Upton DC
        • Johnson M
        • Zelazny SK
        • et al.
        Prospective evaluation of office-based injection laryngoplasty with hyaluronic acid gel.
        Ann Otol Rhinol Laryngol. 2013; 122: 541-546https://doi.org/10.1177/000348941312200901
        • Traboulsi H
        • El Natout T
        • Skaff G
        • et al.
        Adverse reaction to hyaluronic acid injection laryngoplasty: a case report.
        J Voice. 2017; 31: 245.e1-245.e2https://doi.org/10.1016/j.jvoice.2016.08.011
        • Shamanna SG
        • Bosch JD.
        Injection laryngoplasty: a serious reaction to hyaluronic acid.
        J Otolaryngol Head Neck Surg. 2011; 40: E39-E42https://doi.org/10.2310/7070.2011.100283
        • Ramazani F
        • Isaac A
        • Johannsen W
        • et al.
        Side effects and complications of injection laryngoplasty for treatment of congeintal type 1 laryngeal clefts.
        Int J Pediatr Otorhinolaryngol. 2020; 131109886https://doi.org/10.1016/j.ijporl.2020.109886
        • Mangat HS
        • El-Hakim H.
        Injection augmentationof type I laryngeal clefts.
        Otolaryngol Head Neck Surg. 2012; 146: 764-768https://doi.org/10.1177/0194599811434004
        • André P.
        Evaluation of the safety of a no-animal stabilized hyaluronic acid (NASHA - Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001.
        J Eur Acad Dermatology Venereol. 2004; 18: 422-425https://doi.org/10.1111/j.1468-3083.2004.00934.x
        • Justiz Vaillant AA
        • Vashisht R
        • Zito PM
        Immediate Hypersensitivity Reactions. StatPearls Publishing. Treasure Island (FL). 2022; 8